At the news
? NEUTRALIMPACT 2/10 144 filed Aug 13, 2026 at 17:03 ET
Erick Lucera, an officer of Dyne Therapeutics, filed a Form 144 on August 13, 2026, indicating intent to sell 1,797 shares of common stock with an approximate market value of $47,226. The shares were acquired via restricted stock unit vesting on August 12, 2026, and the sale is for equity compensation-related tax obligations. Given the small size relative to the company's $4.9B market cap and the routine nature of RSU-based sales, this filing is neutral.
- Officer Erick Lucera filed Form 144 to sell 1,797 shares of Dyne Therapeutics common stock.
- Estimated sale value is approximately $47,226 based on filing date.
- Shares were acquired via restricted stock unit vesting on August 12, 2026.
- Sale is for equity compensation-related purposes, not a discretionary open-market exit.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access